Cargando…

Association of cardiac myosin-binding protein-C with the ryanodine receptor channel – putative retrograde regulation?

The cardiac muscle ryanodine receptor-Ca(2+) release channel (RyR2) constitutes the sarcoplasmic reticulum (SR) Ca(2+) efflux mechanism that initiates myocyte contraction, while cardiac myosin-binding protein-C (cMyBP-C; also known as MYBPC3) mediates regulation of acto-myosin cross-bridge cycling....

Descripción completa

Detalles Bibliográficos
Autores principales: Stanczyk, Paulina J., Seidel, Monika, White, Judith, Viero, Cedric, George, Christopher H., Zissimopoulos, Spyros, Lai, F. Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104826/
https://www.ncbi.nlm.nih.gov/pubmed/29930088
http://dx.doi.org/10.1242/jcs.210443
Descripción
Sumario:The cardiac muscle ryanodine receptor-Ca(2+) release channel (RyR2) constitutes the sarcoplasmic reticulum (SR) Ca(2+) efflux mechanism that initiates myocyte contraction, while cardiac myosin-binding protein-C (cMyBP-C; also known as MYBPC3) mediates regulation of acto-myosin cross-bridge cycling. In this paper, we provide the first evidence for the presence of direct interaction between these two proteins, forming a RyR2–cMyBP-C complex. The C-terminus of cMyBP-C binds with the RyR2 N-terminus in mammalian cells and the interaction is not mediated by a fibronectin-like domain. Notably, we detected complex formation between both recombinant cMyBP-C and RyR2, as well as between the native proteins in cardiac tissue. Cellular Ca(2+) dynamics in HEK293 cells is altered upon co-expression of cMyBP-C and RyR2, with lowered frequency of RyR2-mediated spontaneous Ca(2+) oscillations, suggesting that cMyBP-C exerts a potential inhibitory effect on RyR2-dependent Ca(2+) release. Discovery of a functional RyR2 association with cMyBP-C provides direct evidence for a putative mechanistic link between cytosolic soluble cMyBP-C and SR-mediated Ca(2+) release, via RyR2. Importantly, this interaction may have clinical relevance to the observed cMyBP-C and RyR2 dysfunction in cardiac pathologies, such as hypertrophic cardiomyopathy.